Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
Here, the authors discover that NGF, upregulated by transcription factor ZBTB46 in prostate cancer exposed to androgen therapy, promotes neuroendocrine differentiation. They show that NGF interacts with the GPCR CHRM4, that both NGF and CHRM4 are upregulated in highly metastatic prostate cancer and...
Guardado en:
Autores principales: | Wei-Yu Chen, Yu-Ching Wen, Shian-Ren Lin, Hsiu-Lien Yeh, Kuo-Ching Jiang, Wei-Hao Chen, Yow-Sien Lin, Qingfu Zhang, Phui-Ly Liew, Michael Hsiao, Jiaoti Huang, Yen-Nien Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e7b7c66702104de49414ef8b54df1488 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer
por: Yu-Ching Wen, et al.
Publicado: (2021) -
Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients
por: Divya Bhagirath, et al.
Publicado: (2021) -
Engineer design process assisted by explainable deep learning network
por: Chia-Wei Hsu, et al.
Publicado: (2021) -
Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
por: Jingci Chen, et al.
Publicado: (2021) -
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Qiuhui Li, et al.
Publicado: (2018)